Transmission, seroprevalence, and maternal-fetal impact of lymphocytic choriomeningitis virus

Pediatr Res. 2024 Jan;95(2):456-463. doi: 10.1038/s41390-023-02859-w. Epub 2023 Oct 19.

Abstract

Congenital infections can have devastating short- and long-term impacts on the developing fetus. Lymphocytic choriomeningitis virus (LCMV) is a zoonotic pathogen of concern that causes a severe congenital syndrome but is under-recognized and under-studied. Herein we review data on the natural animal reservoirs of LCMV, modes of transmission to humans, seroprevalence of LCMV worldwide in both pregnant and non-pregnant individuals, mechanisms of viral dissemination to placenta and fetus, and impact of climate change on viral transmission. We highlight opportunities to enhance awareness of congenital LCMV and provide recommendations for prevention and monitoring among at-risk pregnant people. IMPACT: Key message of the article: LCMV is a zoonotic virus that poses a major threat to maternal-fetal health. Adds to the existing literature: We comprehensively address transmission of LCMV from the natural reservoir to the pregnant individual, placenta, and fetus. Impact: Available data call for enhanced patient and provider awareness about congenital LCMV during pregnancy, as well as a need for efforts to better define the seroprevalence and impact of congenital LCMV worldwide.

Publication types

  • Review

MeSH terms

  • Animals
  • Female
  • Fetal Diseases*
  • Humans
  • Lymphocytic Choriomeningitis* / epidemiology
  • Lymphocytic choriomeningitis virus
  • Placenta
  • Pregnancy
  • Seroepidemiologic Studies